MECOM and leukemia: While Yamazaki et al.14 previously published an EVI1 transgenic model that genetically mimics the 3q26 human leukemias and underlined the significance of GATA2 enhancer, we report the development of the first Evi1-inducible system that allowed us to uncover a mechanism behind EVI1-associated leukemogenesis.